LEVONORGESTREL implant 2 x 75mg + trocar

STD DINJLEVN15I

Valid Article

The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
22.1.5 - Implantable contraceptives
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
G03AC03
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

LEVONORGESTREL implant

Therapeutic Action

Progestogen contraceptive for subdermal insertion.

Implant composed of 2 flexible silicone-based polymer rods.

Each rod is 43 mm in length, 2.5 mm in diameter, and contains 75 mg levonorgestrel.

Indications

Long-acting contraception, for a maximum of five years, after which the implant must be changed.

Instructions for use

To be inserted sub-dermally (subcutaneous use), into the inner side of the non-dominant arm, 8-10 cm from the bony process of the elbow and 3-5 cm below the biceps, under local anaesthetic and aseptically.

Equipment needed for insertion

For information on insertion and removal, follow the manufacturer's instructions.

Implant supplied with a trocar, in set of 10 (= 10 implants + 10 trocars). The minimum order quantity varies according to the supply centres (10 or 100). Code and label are defined per unit (1 implant + 1 trocar).

Therapeutic alternative: etonogestrel implant with a duration of action of 3 years.

Storage

Below 25°C - Protect from sunlight